However, the skin lesions were resistant even to steroidpulse therapy (methyl prednisolone at 500 mg/day for three days) which was performed at the end of the eighth course of mogamulizumab when skin symptoms were most severe. In addition, liver dysfunction (AST at 923 IU/L and ALT at 333 IU/L) occurred during tapering doses of oral corticosteroids. The patient was not infected with hepatitis A, B, C, or E viruses. Viral DNA for EBV, VZV, HSV, and HHV-6 was below detection limits. CMV antigenaemia was not detected. Anti-nuclear, mitochondrial M2, liver/kidney microsome type-1, and smooth muscle actin antibodies were not detected. Serum IgG was normal. Liver biopsy showed centrilobular necrosis and lymphocytic infiltration ( figure 1H ). Based on a diagnosis of acute autoimmune hepatitis [1] due to mogamulizumab, doses of oral corticosteroids were increased to 50 mg/day. However, liver dysfunction did not improve and became most prominent two months after the eighth course of mogamulizumab. The patient was then administered oral azathioprine (100 mg/day). Notably, there was a rapid remission of skin lesions within one month, and levels of AST and ALT returned to normal within six months. Hepatitis is now well-controlled with prednisolone (6 mg/day) and azathioprine (25 mg/day). However, small nodules of ATLL recurred on her left upper arm, ten months after the eighth course of mogamulizumab, which were then treated with local radiation therapy. Mogamulizumab is an anti-CCR4 antibody which eradicates CCR4 positive lymphocytic tumour cells by antibody-dependent cellular cytotoxicity [2, 3] . Since normal regulatory T cells (Tregs) also express CCR4, mogamulizumab eliminates Tregs [3] concomitantly with CCR4-expessing tumour cells. In our patient, mogamulizumab decreased the prevalence of blood CD4 and CD25 cells from 57.4% and 26.2% to 10.7% and 3.8%, respectively, suggesting effective elimination of Tregs. These changes were maintained even up to five months after the final administration of mogamulizumab. Although elimination of Tregs promotes anti-tumour immunity, it is associated with an increased risk of various adverse events due to activation of autoreactive T cells. These events include Stevens-Johnson syndrome [4], graft-versus-host disease-like colitis [5] , and hepatitis associated with hepatitis B virus reactivation [6] . The present case was complicated by toxicoderma-like eruptions and autoimmune hepatitis that were resistant to systemic corticosteroids. However, six weeks of azathioprine treatment resulted in an improvement in skin symptoms and liver function, accompanied by a partial recovery of CD4 and CD25 cells (53.4% and 12.7%, respectively). Collectively, azathioprine may be a useful therapeutic option for adverse cutaneous and hepatic events induced by the immunomodulatory effects of mogamulizumab.
Granulomatous reaction to permanent eyebrow makeup successfully treated with topical steroids in combination with topical tacrolimus
Permanent eyebrow makeup (PEMU) is a cosmetic tattoo involving intradermal injection of colourants by piercing the skin with needles, as for traditional tattoos [1, 2] . Although PEMU can cause several adverse reactions, similar to traditional tattoos, the risks are not fully known. Morales-Callaghan [3] reported that 3-8% of the general population has some type of traditional tattoo. Incel [4] reported that 2.1% of traditional tattoos are associated with adverse reactions. PEMU, mistakenly considered as a cosmetic, has become increasingly popular, and the incidence rates of adverse reactions have not been established [1, 2] . Frequent adverse reactions are local inflammation, infection, and allergic reactions [1] [2] [3] [4] [5] [6] . PEMU contains black or brown colourants that were reported to be associated with systemic sarcoidosis [3, 6] . PEMU can cause granulomatous reactions, which may be early manifestations of systemic sarcoidosis [3, 4, [6] [7] [8] .
A 32-year-old Japanese woman presented with papules on her right eyebrow ( figure 1 A) . She had a history of PEMU with no immediate complications, four years prior to the assessment. She had no history of keloids, atopic disorders, or allergies, and no remarkable family medical history. The histological examination revealed epithelioid granulomas in the dermis, with scattered brownish-black colourants and slight lymphocytic infiltrations ( figure 1B-D) . ZiehlNeelsen immunohistochemical staining was negative. Patch test results with the PEMU products were negative. Physical examinations, including chest radiography, electrocardiogram, laboratory tests (such as angiotensin-converting enzyme), and eye examination revealed no abnormal findings. Based on clinical and histopathological findings, the skin lesions were diagnosed as a granulomatous reaction to the colourants. Some reports have suggested the efficacy of steroids, tacrolimus, allopurinol, and laser ablation [2, 5, 6] . The patient's symptoms were not completely resolved with twice-daily use of a medium-potent topical steroid for two weeks. Serup [6] described the difficulty in predicting laser ablation outcomes because various colourants of tattoos have different absorption spectra and wavelengths. Moreover, PEMU treatment by laser ablation is difficult because of the remaining eyebrow hair. Therefore, twice-daily use of topical tacrolimus was administered, resulting in marked improvement one week later. Although the lesion recurred several weeks after the treatment was terminated, her symptoms had been completely suppressed by twice-daily use of a medium-potent topical steroid for one week, followed by twice-daily use of topical tacrolimus for one week, and concluded with the twiceweekly proactive use of topical tacrolimus. This sequential administration of topical steroids and topical tacrolimus was more beneficial than the administration of either agent alone.
Because PEMU can be performed outside the hospital, there is a risk of infection and a lack of risk management. Although our case showed negative Ziehl-Neelsen staining, some cases infected with mycobacteria have been reported [1] . Wenzel [2] reported that several colourants have not been tested for use in PEMU and have caused adverse reactions. Ravits [9] categorized adverse reactions, and the symptoms seen in our case can be categorized as a foreign body-like reaction. The colourants in and around the granulomas suggest this possibility, but should not be an exclusionary criterion for a diagnosis of systemic sarcoidosis because the foreign body-like reaction on a tattoo can be a first sign of systemic sarcoidosis [3, 4, [6] [7] [8] . Ohtsuka [8] reviewed 12 Japanese cases of systemic sarcoidosis associated with traditional tattoos, and some reports recommended systemic work-up for patients with skin eruptions on tattoos [3, 4, [6] [7] [8] . No sign of systemic sarcoidosis was identified in our patient. Several reports, however, have suggested that the time frame for development of sarcoidal reaction may vary from days to years [2, 3, 7] . Thus, our patient should be followed regularly. The removal of pathogenic colourants is difficult, and the persistence of colourants in the dermis may cause long-lasting recurrent adverse reactions, requiring continual treatments such as topical or oral steroids, tacrolimus, allopurinol, or laser ablation [2, 5, 6] . In our case, the symptoms were suppressed by the sequential administration of topical steroids and topical tacrolimus, but the patient still requires continual treatment. Although no predictive tests have yet been utilized to estimate individual risk of developing adverse reactions [2] , patch tests and intracutaneous tests may have predictive value [9] . In conclusion, we provide single-case evidence that treatment with topical steroids, in combination with topical tacrolimus, can be effective for PEMU, which may be of interest to consumers, beauticians, and clinicians regarding the possible risks of long-lasting adverse reactions to PEMU. 
Disclosure

Multiple myeloma presenting with acquired cutis laxa and primary systemic amyloidosis
Cutis laxa is an inherited or acquired disorder, characterized clinically by loose pendulous skin and histologically by the abnormal production or destruction of dermal elastic fibres [1] [2] [3] [4] . Acquired cutis laxa (ACL) is rare and occurs in adulthood [2] [3] [4] . ACL has been reported in association with drugs and various conditions, including multiple myeloma (MM) and amyloidosis [2] . Although the pathomechanism of ACL in MM remains unclear, it is believed to be immunemediated [1] . Primary amyloid light chain (AL) amyloidosis is the most common form of systemic amyloidosis [5] and may be associated with clonal lymphoid diseases in which immunoglobulins are produced, including MM [3] . A 54-year-old Korean woman visited the dermatology department of our hospital with a one-year history of easy bruising. Her medical and family histories were unremarkable. There was no history of topical or systemic corticosteroid administration. Physical examination revealed hypopigmented patches with skin laxity and purpura on both flanks and periorbital purpura ( figure 1A-C) . On the thumbs, soft, loose and wrinkled skin was observed ( figure 1 D) . When pressure was applied to the end of the thumbs, a slight depression of the skin abnormally continued ( figure 1E) . The skin from a hypopigmented patch on the flank was biopsied, and no significant abnormalities were observed on routine hematoxylin-eosin staining ( figure 1F) . However, Verhoeff-van Gieson staining showed reduction and fragmentation of elastic fibres in the reticular dermis, and von A B C D F G E Figure 1 . A) Periorbital purpura. B, C) Hypopigmented patches with skin laxity and purpura on the lower abdomen and both flanks. D) Soft, sagging and wrinkled skin at the tip of the thumb. E) A prolonged slight depression of skin (black arrow) following pressure on the thumbs. F) A scanty inflammatory cell infiltrate is observed in perivascular areas, but the thickness and appearance of the dermis are normal (H&E; ×12.5). G) Reduction and fragmentation of elastic fibres in the reticular dermis (Verhoeff-van Gieson staining; ×100).
Kossa staining was negative, which confirmed the diagnosis of ACL ( figure 1G ). Congo-red staining was negative. It was necessary to evaluate systemic amyloidosis because periorbital purpura was observed. Therefore, needle biopsies of the abdominal subcutaneous fat pad were performed. These showed an amorphous eosinophilic substance that stained positive for Congo-red and exhibited green birefringence under polarized light, prompting the diagnosis of amyloidosis. In addition, an electromyogram revealed bilateral carpal tunnel syndrome which is related to amyloidosis. Laboratory examinations showed macrocytic normochromic anaemia, an inverted albumin-to-globulin ratio, IgA-lambda monoclonal gammopathy, Bence-Jones proteinaemia with proteinuria, and 30-40% immature plasma cells in a bone marrow aspirate, establishing a diagnosis of MM. The final diagnoses were ACL and primary systemic amyloidosis, accompanied by MM. In contrast to other published cases [1, 4] in which cutis laxa was associated histologically with amyloid and light chain deposits, interestingly, this was not observed in our case. Regarding one case with a triple association [3] , as in our case, amyloid and light chain deposits could not be observed on histological examination of laxity of the axilla but were observed on skin biopsy of periorbital purpura. ACL is associated with several conditions, including systemic lupus erythematosus, lymphoma, MM, and amyloidosis [2] . ACL is related to a high rate of systemic elastolysis, resulting in the development of pulmonary emphysema, aortic aneurysms, and intestinal diverticula [2, 3] . However, no other organ was involved in our patient. Cutaneous changes occur in up to 40% of amyloidosis cases and include purpura, waxy papules, plaques and nodules on skinfolds of the central face, and macroglossia [3, 4] . Purpura is the most common symptom and periorbital purpura (raccoon eyes) is the characteristic lesion [3] . Carpal tunnel syndrome, which was diagnosed in our patient, may occur in primary systemic amyloidosis cases [3, 6] .
